bioRxivBioinformaticsPreprint
Systematic Mining of gut microbiota biomarkers for IBD
Yuchen ZhangiD, Wenkai LaiiD, Meiling WangiD, Shirong Lai, Qing LiuiD, Qi LuoiD, Lijun DouiD, Fenglong YangiD
Abstract
BackgroundInflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohns disease (CD), represents a chronic inflammatory condition with an incompletely understood etiology. Emerging evidence suggests that alterations in gut microbiota composition play a pivotal role in disease development. Here, we leveraged gut fecal metagenomic data (3044 samples: 2248 IBD and 796 healthy) from publicly available sources to explore microbiome biomarkers related to IBD to provide new ideas for clinical treatment. ResultsOur analyses revealed marked disparities in microbial species abundance and composition between IBD and healthy samples in both male and female subjects from the United States, whereas such distinctions were absent in subjects from Spain. Hierarchical and systematic investigations uncovered microbial phyla, such as Verrucomicrobia and Firmicutes, associated with IBD in US cohorts. Furthermore, we identified 127 highly correlated pathways with these differential microbes, covering functions such as peptidoglycan biosynthesis III, dTDP-L-rhamnose biosynthesis I, starch degradation, and glucose-1-phosphate degradation. Gut microbial metabolites were predicted based on metagenomic data using the MelonnPan workflow and 16 metabolites with significant differences were identified that collectively contribute to energy metabolism, digestion, skin integrity and general bodily function. ConclusionsThis study identified differences in microbial species and metabolic pathways related to Inflammatory Bowel Disease (IBD) through hierarchical and systematic analysis, which can aid in the clinical diagnosis of IBD. Pathways such as Peptidoglycan Biosynthesis III and dTDP-L-Rhamnose Biosynthesis I are associated with the generation of bacterial cell walls, and disruptions in these pathways affect bacterial activity, leading to an imbalance in the hosts gut microbiota. Based on the hypotheses regarding the pathogenesis of IBD derived from the above mining results, it provides a theoretical basis for selecting precise treatment options.
- organism: human
- assay: metagenomics
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated 16S rRNA Bioinformatics Analysis of Gut Microbiota, Predicted Pathways, and Candidate Biomarkers in Inflammatory Bowel Disease
Aman Zehra, Elamathi Natarajan·bioRxiv·Oct 19, 2026
- The faecal metabolome and its determinants in inflammatory bowel disease
A. Vich Vila, S. Hu, … R. K. Weersma·bioRxiv·Jun 15, 2022
- Inferring intestinal mucosal immune cell associated microbiome species and microbiota-derived metabolites in inflammatory bowel disease
Rajagopalan Lakshmi Narasimhan, Allison A. Throm, … Jiajian Liu·bioRxiv·Sep 18, 2020
- Development of Inflammatory Bowel Disease is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice
T. J. Sharpton, S. Lyalina, … K. S. Pollard·bioRxiv·Aug 10, 2017
- Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease
S. Hu, A. R. Bourgonje, … R. K. Weersma·bioRxiv·Jun 4, 2022
- Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease
N. Chamorro, D. A. Montero, … R. M. Vidal·Microbial CellPeer-reviewed·Sep 6, 2021